|
[Related PubMed/MEDLINE] Total Number of Papers: 11
|
|
|
[Display Entries]
|
|
[Entries Per Page]
|
per page
|
|
Page Control
|
|
Page: of
|
|
|
|
Abbreviation |
: PEAK1 |
Long Form |
: pseudopodium-enriched atypical kinase 1 |
|
No. |
Year |
Title |
Co-occurring Abbreviation |
1 |
2022 |
Exosome-delivered circSATB2 targets the miR-330-5p/PEAK1 axis to regulate proliferation, migration and invasion of lung cancer cells. |
circRNA, miR-330-5p, sh |
2 |
2021 |
PEAK1 promotes invasion and metastasis and confers drug resistance in breast cancer. |
--- |
3 |
2021 |
Pseudopodium enriched atypical kinase 1(PEAK1) promotes invasion and of melanoma cells by activating JAK/STAT3 signals. |
CCK-8 |
4 |
2020 |
Circ-PGAM1 promotes malignant progression of epithelial ovarian cancer through regulation of the miR-542-3p/CDC5L/PEAK1 pathway. |
CDC5L, ChIP, circ-PGAM1, EOC |
5 |
2020 |
Phospho-PTM proteomic discovery of novel EPO- modulated kinases and phosphatases, including PTPN18 as a positive regulator of EPOR/JAK2 Signaling. |
AAK1, AKT, CKD, EPO, GUK1, JAK2, MDS, MPP1, p-Y PTM, PHPT1, PTPN18, PTPRA, rhEPO, STAT5, UBASH3B |
6 |
2018 |
Overexpression of PEAK1 contributes to epithelial-mesenchymal transition and tumor metastasis in lung cancer through modulating ERK1/2 and JAK2 signaling. |
EMT, JAK2, MMP-2 |
7 |
2018 |
The PEAK1-PPP1R12B axis inhibits tumor growth and metastasis by regulating Grb2/PI3K/Akt signalling in colorectal cancer. |
CRC, PPP1R12B |
8 |
2017 |
Inhibition of Discoidin Domain Receptor 1 Reduces Collagen-mediated Tumorigenicity in Pancreatic Ductal Adenocarcinoma. |
DDR1, ECM, PDA, Pyk2 |
9 |
2014 |
Analysis of a cytoskeleton-associated kinase PEAK1 and E-cadherin in gastric cancer. |
--- |
10 |
2012 |
Dynamic phosphorylation of tyrosine 665 in pseudopodium-enriched atypical kinase 1 (PEAK1) is essential for the regulation of cell migration and focal adhesion turnover. |
FA |
11 |
2010 |
Pseudopodium-enriched atypical kinase 1 regulates the cytoskeleton and cancer progression [corrected]. |
EGFR |
|